N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
ATC group of level 5 – chemical substance · in plain English: medicines for Parkinson's disease
This site has the patient leaflet or the SPC of 41 medicines in this group.
- 22 prescription only (POM)
Place in the ATC classification
- N Nervous system drugs 4,479 medicines
- N04 Anti-parkinson drugs 315 medicines
- N04B Dopaminergic agents 292 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor 41 medicines
- N04BA Dopa and dopa derivatives 83 medicines
- N04B Dopaminergic agents 292 medicines
- N04 Anti-parkinson drugs 315 medicines
Active substances in the group
- Carbidopa 34 medicines
- Entacapone 33 medicines
- Levodopa 34 medicines
Medicines
Other groups of the same level
- N04BA01 levodopa 2 medicines
- N04BA02 levodopa and decarboxylase inhibitor 40 medicines
Other names of the ATC group
- Czech: N04BA03 Levodopa, inhibitor dekarboxylasy a inhibitor COMT
- French: N04BA03 lévodopa, inhibiteur de la décarboxylase et inhibiteur de la comt
- German: N04BA03 Levodopa, Decarboxylasehemmer und COMT-Hemmer
- Spanish: N04BA03 LEVODOPA+INHIBIDOR CARBOXILASA+INHIBIDOR COMT
- German: N04BA03 Levodopa, Decarboxylasehemmer und COMT-Hemmer
- Italian: N04BA03 LEVODOPA
- Polish: N04BA03 LEWODOPA, INHIBITOR DEKARBOKSYLAZY I INHIBITOR COMT
- Turkish: N04BA03 levodopa, dekarboksilaz inhibitörü ve COMT inhibitörü
- Portuguese (Brazil): N04BA03 Levodopa + inibidor de decarboxilase + combinação de inibidores
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group N04BA03
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
